Company intelligence / Profile preview

Shandong Boyuan Pharmaceutical

Ownership: Private
Employees: ~667
Development stage: Commercial

Overview

Shandong Boyuan is a leading Chinese manufacturer of active pharmaceutical ingredients and intermediates with over two decades of experience. The company supplies a broad portfolio of APIs for oncology, antifungal therapy, anesthesia/pain management, cardiovascular disease and diabetes. Its products are exported globally and manufactured under GMP standards in large-scale facilities in Shandong province.

Therapeutic areas: OncologyEndocrinologyOtherCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

5 assets

oxaliplatin

Commercial

Indications: Cancer

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shandong Boyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Boyuan Pharmaceutical.

Explore the full profile